STAT+: The China debate gets louder in Washington

Article excerpt

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi from BIO! I’m sitting in the frigid media room here next to STAT’s Brittany Trang, who is writing something scintillating about artificial intelligence.  Today, we’ve got Lilly chasing aesthetics with a AI-designed experimental hair loss drug from Absci, see a stark rise in the U.S. health care spending, and consider China’s ever-rising presence in biopharma.  Continue to STAT+ to read the full story…